ArticleScientific reports2025

Real-world data of dacomitinib as first-line treatment for patients with EGFR-mutant non-small-cell lung cancer.

Ji Eun Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.